We assessed the efficacy and basic safety of R-CHOP versus mixture therapy with bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone in patients with newly diagnosed disease in whom stem-cell transplantation had not been an option. Methods Study Patients From May 2008 through December 2011, we enrolled patients at 128 sites in 28 countries across Europe, Asia, THE UNITED STATES, and South America. Adults with recently diagnosed stage II, III, or IV mantle-cell lymphoma who had been ineligible or not really considered for stem-cell transplantation had been eligible. The medical diagnosis was verified on central pathological review. The trial was conducted based on the provisions of the Declaration of Helsinki, Good Clinical Practice guidelines, and regional regulatory requirements.Oklahoma is ‘currently moving on related legislation,’ regarding to AUL. Abortion-rights advocates, however, say the legislation seeks to make abortion in effect unlawful by imposing insurmountable hurdles, such as needing screening for a broad selection of risk factors. The other day, the Senate voted 21-10 to pass legislation requiring a health care provider to perform a sonogram at least two hours before a woman has an abortion. The variations of the bill in mind in the House are in this aspect more stringent; they might need the sonogram to occur at least a day ahead of the abortion . This content was reprinted from kaiserhealthnews.org with permission from the Henry J.